Antimyostatin Treatment in Health and Disease: The Story of Great Expectations and Limited Success

In the past 20 years, myostatin, a negative regulator of muscle mass, has attracted attention as a potential therapeutic target in muscular dystrophies and other conditions. Preclinical studies have shown potential for increasing muscular mass and ameliorating the pathological features of dystrophic...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Tue L., Vissing, John, Krag, Thomas O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001237/
https://www.ncbi.nlm.nih.gov/pubmed/33802348
http://dx.doi.org/10.3390/cells10030533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001237/
https://www.ncbi.nlm.nih.gov/pubmed/33802348
http://dx.doi.org/10.3390/cells10030533

Ejemplares similares